- Drugs
- Friday, 15 May 2020
Sanofi says COVID-19 vaccine will be available globally at the same time
Sanofi will ensure that a potential vaccine against COVID-19, if approved, reaches all regions of the world at the same time, the chairman of the French drugmaker said on Thursday.
“There will be no particular advance given to any country,” Serge Weinberg told France 2 television.
“We are organised with several manufacturing units. Some of them are in the United States but even more of them are in Europe and France,” he said.
Sanofi operates 73 industrial locations in 32 countries. There is no vaccine approved yet against COVID-19, the illness caused by the new coronavirus.
The group’s chief executive Paul Hudson said on Thursday it was vital that any coronavirus vaccine reach all parts of the world, after angering the French government earlier by saying the United States would get priority access.
Related Industry Updates
Pulmonary Arterial Hypertension Market is expected to reach US$ 10,889.08 million by 2028
Jan 02, 2023
North America In-Office Teeth Whitening Products Market is expected to reach US$ 5,818.23 million by 2028
Apr 21, 2023
Brazil Vitamin K2 Market is expected to reach US$ 9.81 million by 2028
Jun 09, 2023
Europe Small Molecule Drug Delivery Market: Industry Overview, Trends and Growth Opportunities Forecasted Till 2027
Aug 25, 2020
Drug Delivery Market is expected to reach US$ 32,54,594.2 million by 2028
May 23, 2023
Tocotrienol Market Estimated to Expand at a Robust CAGR over 2020-2027
Mar 15, 2021
Pharmaceutical Contract Sales Organizations Market is expected to reach US$ 15,820.86 million by 2030
Oct 11, 2023
Follow us on
